FDA Recalls and Continuous Glucose Monitor Safety Concerns

The FDA monitors medical devices for potential safety issues, recalls, manufacturing problems, software defects, and reports of patient injuries. Several glucose monitoring devices and related diabetic management systems have been the subject of FDA recalls, safety communications, or corrective actions involving concerns about device accuracy, software problems, delayed alerts, sensor failures, or other issues that may interfere with a patient’s ability to safely manage blood sugar levels.

Continuous glucose monitors are designed to provide patients with ongoing glucose data throughout the day and night. Many users rely heavily on these systems to warn them of dangerous glucose events before symptoms become severe. When a glucose monitoring system allegedly fails to function properly, the consequences may become serious very quickly.

Some reported concerns involving continuous glucose monitors include:

• Inaccurate glucose readings
• Delayed low glucose alerts
• Missed high glucose warnings
• Sensor failures
• Software malfunctions
• Connectivity interruptions
• Device shutdowns
• Calibration errors
• False glucose alarms
• Failure to transmit critical glucose data

For many patients, especially children, insulin-dependent diabetics, and individuals with hypoglycemia unawareness, these devices may play a critical role in daily medical management. Allegations involving defective glucose monitoring devices often focus on whether manufacturers adequately tested their products, properly warned consumers, responded quickly to reported problems, or implemented timely recalls and corrective actions.

How Continuous Glucose Monitors Work

Continuous glucose monitors use small wearable sensors placed on the body to measure glucose levels in real time. These sensors are typically connected to smartphone apps, insulin pumps, handheld readers, or alert systems that notify users when glucose levels become dangerously high or low.

Unlike traditional fingerstick testing, continuous glucose monitors are designed to provide ongoing monitoring throughout the day. Many patients rely on these devices while sleeping, driving, exercising, working, or caring for children. Because patients may make insulin dosing decisions based on CGM readings, accuracy is extremely important.

Some patients use continuous glucose monitors alongside insulin pumps or automated insulin delivery systems. In these situations, inaccurate readings may create additional risks if insulin delivery decisions are based on incorrect glucose data.

Reported Injuries and Complications

Seizures and Loss of Consciousness

In some situations, diabetic emergencies allegedly linked to faulty glucose monitor readings have resulted in seizures, fainting, blackouts, falls, vehicle accidents, or other traumatic events.

Children and individuals with hypoglycemia unawareness may face especially serious risks because they may not immediately recognize symptoms of dangerous glucose changes without proper device alerts.

Hospitalization and Emergency Medical Treatment

Some individuals reporting continuous glucose monitor problems required hospitalization, emergency room treatment, ambulance transport, or intensive diabetic intervention after severe glucose events.

Families often describe these situations as traumatic and emotionally overwhelming, particularly when they believed the monitoring device was functioning properly.

FDA Recall Investigations and Safety Monitoring

The FDA may issue recalls or safety communications involving medical devices when regulators identify manufacturing issues, software defects, labeling concerns, or risks to patient safety. Some recalls involve product corrections or software updates, while others may involve removal of products from the market.

FDA recalls are often categorized based on the level of potential health risk:

• Class I Recall – Risk of serious injury or death
• Class II Recall – Temporary or medically reversible injury risk
• Class III Recall – Lower likelihood of serious injury

Not every recall results in litigation, and not every recalled product causes injury. However, when patients allegedly suffer serious harm linked to recalled or defective medical devices, legal claims may follow.

Who May Qualify for a Continuous Glucose Monitor Lawsuit?

Individuals who experienced serious diabetic emergencies, injuries, hospitalization, or other complications after using a recalled or allegedly defective continuous glucose monitor may qualify for further legal review.

Potential claims may involve:

• FDA recalled glucose monitors
• Inaccurate glucose readings
• Failure to provide alerts
• Sensor malfunctions
• Software or connectivity failures
• Hypoglycemic emergencies
• Hyperglycemic events
• Hospitalization or emergency treatment
• Seizures or loss of consciousness

Every situation is different. Speaking with our staff can help you better understand whether your circumstances may qualify for a Continuous Glucose Monitor Lawsuit review.

Helpful Information May Include:

• Name of the glucose monitor device
• Model or serial numbers
• FDA recall notices
• Medical records
• Hospital records
• Emergency room treatment records
• Insulin dosing records
• Device screenshots or app history
• Photos of the device
• Pharmacy or insurance records

Keeping documentation related to the device and any related injuries may help preserve important information later during the review process.

Potential Compensation in a Continuous Glucose Monitor Lawsuit

Compensation in a Continuous Glucose Monitor Lawsuit may depend on the severity of the injuries, medical treatment required, and the specific facts surrounding the claim.

Potential damages may include:

• Medical expenses
• Hospital bills
• Emergency treatment costs
• Lost wages
• Pain and suffering
• Emotional distress
• Long-term medical complications
• Future medical treatment

Not every individual will qualify for compensation, and outcomes vary depending on the specific facts of each case.